Vaccine Information Statement (VIS) -- Diphtheria, Tetanus, and Pertussis (DTaP) Vaccines: What You Need to Know
This two-page Vaccine Information Statement (VIS) educates people about the DTaP vaccine for diphtheria, tetanus (Lockjaw), and pertussis (whooping cough). It describes symptoms, transmission, and effects of each disease. It explains why people should get the DTaP vaccine, who should be vaccinated and when, and who should not get the vaccine or should wait. It outlines protection for older people through a vaccine called Tdap, which is similar to DTaP. It identifies risks and side effects, distinguishes between common, uncommon and very rare problems, and explains what to look for and what to do in the event of a serious reaction. Contact information for the National Vaccine Injury Compensation Program (VICP) is provided, along with tips for how people can learn more about the DTap vaccines.
The English-language VIS was created by the Centers for Disease Control and Prevention (CDC) National Center for Immunization and Respiratory Diseases. The translations are provided by the Immunization Action Coalition (IAC) and its partner organizations. The Arabic, Chinese - simplified, Chinese - traditional, Chuukese, French, Ilokano, Marshallese, Pohnpeian, Portuguese, Russian, Samoan, Somali, Spanish, Tongan, Turkish, and Vietnamese translations are updated to the August 2018 VIS; the other translations from IAC are based on the 05/17/2007 CDC version. The August 2018 VIS for DTaP has changed from the 2007 version in that it reflects changes to the recommendations of the Advisory Committee on Immunization Practices with regard to contraindications and precautions for vaccination.
A qualified translation company performed an independent review by a second translator, and a client advocate.